<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00200005</url>
  </required_header>
  <id_info>
    <org_study_id>Mdt-301 November 03,1998</org_study_id>
    <secondary_id>Mdt-301 (Nov 03, 98),</secondary_id>
    <secondary_id>Amendment I (Dec 14, 99),</secondary_id>
    <secondary_id>Amendment II (Jan 31, 02)</secondary_id>
    <secondary_id>Amendment III (Jul 01, 2009)</secondary_id>
    <nct_id>NCT00200005</nct_id>
  </id_info>
  <brief_title>Sacral Nerve Stimulation for Anal Incontinence and Bowel Control</brief_title>
  <acronym>MDT-301</acronym>
  <official_title>Sacral Nerve Stimulation for Anal Incontinence and Bowel Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter European study to evaluate efficacy and safety of sacral nerve stimulation with
      InterStim Therapy to treat fecal incontinence or constipation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 1998</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FI - number of FI episodes per week and/or number of days with FI per week. Constipation - number of bowel movements per week; &amp;/or decrease defecations requiring straining; &amp;/or decrease defecations where there was incomplete emptying</measure>
    <time_frame>Annually</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>FI-number of days with staining/week;urgency with continent bowel movements; Improvement in QOL;* Improvement in anal canal pressure. Constipation - Improvement in Wexner constipation score; QOL.</measure>
    <time_frame>Annually</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Fecal Incontinence and Constipation</condition>
  <arm_group>
    <arm_group_label>InterStim therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients being treated with sacral neuromodulation with InterStim therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Type: Implantable neurostimulator; InterStim</intervention_name>
    <description>Treatment with InterStim Therapy: all patients meeting inclusion/exclusion criteria undergo test screening and those who have successful outcomes receive a permanent implant.</description>
    <arm_group_label>InterStim therapy</arm_group_label>
    <other_name>InterStim Model 3023</other_name>
    <other_name>InterStim Model 3058</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        140 patients (7 study groups, up to 20 implanted patients per study group)

        Fecal Incontinence groups:

        Main Inclusion Criteria:

          -  Fecal incontinence (defined as incontinence to solid or liquid stool &gt; 1 / week);

          -  Failed biofeedback or medical therapy;

        Groups 1 - 5 patients with:

          -  Group 1) Circumferentially intact external anal sphincter, no previous surgery;

          -  Group 2) Circumferentially intact external anal sphincter after surgical repair;

          -  Group 3) Rectal prolapse repaired with a rectopexy;

          -  Group 4) Spinal injury including disc prolapse;

          -  Group 5) Sigmoid or partial rectal resection with colorectal or coloanal anastomosis

        Constipation groups:

        Main Inclusion Criteria:

          -  Chronic constipation (defined as &lt;/= 2 weekly bowel movements; and/or &gt;25% of bowel
             movements required straining; and/or &gt;25% of bowel movements patient did not feel
             empty afterwards) with symptoms more than 1 year

          -  Failed biofeedback or medical therapy;

        Groups 6 - 7 patients with:

          -  Group 6) Idiopathic slow transit constipation as proven on colonic transit studies;

          -  Group 7) Normal colonic transit studies but chronic constipation due to either pelvic
             floor dysfunction or disordered defecation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Matzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Erlangen- Erlangen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael A Kamm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent's Hospital- Melbourne, Australia. Former: St. Mark's Hospital, London, U.K.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cor Baeten, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Hospital- The Netherlands</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Christiansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herlev Hospital- Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders Mellgren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danderyd Hospital- Stockholm, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harald Rosen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danube Hospital/SMZ-Ost- Vienna, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Albert Navarro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Mutua de Terrassa- Terrassa, Spain</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Madoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota- Minneapolis, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolynne Vaizey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Mark's Hospital- London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claes Johansson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danderyd Hospital- Stockholm, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soren Laurberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital- Aarhus, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danube Hospital/SMZ-Ost</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Erlangen</name>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Hospital</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mutua de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danderyd Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mark's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet. 1995 Oct 28;346(8983):1124-7.</citation>
    <PMID>7475602</PMID>
  </reference>
  <results_reference>
    <citation>Matzel KE, Kamm MA, Stösser M, Baeten CG, Christiansen J, Madoff R, Mellgren A, Nicholls RJ, Rius J, Rosen H. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet. 2004 Apr 17;363(9417):1270-6.</citation>
    <PMID>15094271</PMID>
  </results_reference>
  <results_reference>
    <citation>Jarrett ME, Matzel KE, Stösser M, Baeten CG, Kamm MA. Sacral nerve stimulation for fecal incontinence following surgery for rectal prolapse repair: a multicenter study. Dis Colon Rectum. 2005 Jun;48(6):1243-8.</citation>
    <PMID>15793647</PMID>
  </results_reference>
  <results_reference>
    <citation>Jarrett ME, Matzel KE, Christiansen J, Baeten CG, Rosen H, Bittorf B, Stösser M, Madoff R, Kamm MA. Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. Br J Surg. 2005 Jun;92(6):734-9.</citation>
    <PMID>15838899</PMID>
  </results_reference>
  <results_reference>
    <citation>Jarrett ME, Matzel KE, Stösser M, Christiansen J, Rosen H, Kamm MA. Sacral nerve stimulation for faecal incontinence following a rectosigmoid resection for colorectal cancer. Int J Colorectal Dis. 2005 Sep;20(5):446-51. Epub 2005 Apr 21.</citation>
    <PMID>15843939</PMID>
  </results_reference>
  <results_reference>
    <citation>Kamm MA, Dudding TC, Melenhorst J, Jarrett M, Wang Z, Buntzen S, Johansson C, Laurberg S, Rosen H, Vaizey CJ, Matzel K, Baeten C. Sacral nerve stimulation for intractable constipation. Gut. 2010 Mar;59(3):333-40. doi: 10.1136/gut.2009.187989.</citation>
    <PMID>20207638</PMID>
  </results_reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>January 9, 2014</last_update_submitted>
  <last_update_submitted_qc>January 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Slow transit constipation</keyword>
  <keyword>Fecal incontinence</keyword>
  <keyword>Constipation</keyword>
  <keyword>Idiopathic slow transit constipation</keyword>
  <keyword>Chronic constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

